Koichiro Tsujimaru
Nessuna posizione attualmente
Profilo
Koichiro Tsujimaru was the President & Director of DNAFORM KK, Director of AQUA Therapeutics Co., Ltd., and Principal at Nippon Sanso Holdings Corp.
He holds a doctorate degree from Osaka Prefecture University, which was conferred in 2007.
Precedenti posizioni note di Koichiro Tsujimaru
Società | Posizione | Fine |
---|---|---|
AQUA Therapeutics Co., Ltd.
AQUA Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology AQUA Therapeutics Co., Ltd. develops therapeutic drugs focused on the treatment of ophthalmological diseases. It uses a nucleic acid interference platform aimed at gene targets of select diseases. The firm's technologies include diabetic retinopathy, Periostin, and Bonac nucleic acid. It also offers research, development, manufacture, and marketing of other pharmaceuticals; non-medicinal products and cosmetics; and medical devices, instruments, and equipment. The firm also conducts medical research and consulting services. The company was founded by Kazunori Yoshikawa on March 19, 2012 and is headquartered in Kobe, Japan. | Direttore/Membro del Consiglio | - |
NIPPON SANSO HOLDINGS CORPORATION | Corporate Officer/Principal | - |
DNAFORM KK
DNAFORM KK Miscellaneous Commercial ServicesCommercial Services DNAFORM KK provides research and development for transcriptome analysis and cloning. Its products and services include solutions for gene expression analysis, DNA/RNA amplification, custom eprobe/eprimer, cDNA clones and other genetic resources. The company was founded in September 1998 and is headquartered in Yokohama, Japan. | Presidente | - |
Formazione di Koichiro Tsujimaru
Osaka Prefecture University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
NIPPON SANSO HOLDINGS CORPORATION | Process Industries |
Aziende private | 2 |
---|---|
DNAFORM KK
DNAFORM KK Miscellaneous Commercial ServicesCommercial Services DNAFORM KK provides research and development for transcriptome analysis and cloning. Its products and services include solutions for gene expression analysis, DNA/RNA amplification, custom eprobe/eprimer, cDNA clones and other genetic resources. The company was founded in September 1998 and is headquartered in Yokohama, Japan. | Commercial Services |
AQUA Therapeutics Co., Ltd.
AQUA Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology AQUA Therapeutics Co., Ltd. develops therapeutic drugs focused on the treatment of ophthalmological diseases. It uses a nucleic acid interference platform aimed at gene targets of select diseases. The firm's technologies include diabetic retinopathy, Periostin, and Bonac nucleic acid. It also offers research, development, manufacture, and marketing of other pharmaceuticals; non-medicinal products and cosmetics; and medical devices, instruments, and equipment. The firm also conducts medical research and consulting services. The company was founded by Kazunori Yoshikawa on March 19, 2012 and is headquartered in Kobe, Japan. | Health Technology |
- Borsa valori
- Insiders
- Koichiro Tsujimaru